Clearwater International advises Adelis Equity on the sale of Nordentic to Corus
Clearwater International has advised Adelis Equity on the sale of Nordentic, the largest dental laboratory company in Scandinavia, to Corus, the all-round supplier of advanced dental solutions. Adelis divests the business after successfully developing it since 2017 and completing several add-on acquisitions.
Under Adelis’ ownership, Nordentic has seen over 20 labs come together as one group, developing as a pioneer in the technical development of the industry. By combining management’s deep industrial knowledge with strategic acquisitions and investments in lab technology, the company has evolved into one of Europe’s leading dental labs group, solely focusing on onshore and local production.
Corus is backed by Careventures, a pan-European private equity firm and Quadrum Capital, a Netherlands-based investment company. With centralised service centres in Barcelona and Amersfoort, Netherlands, Corus is the leading European provider of cutting-edge dental prostheses and orthodontics. Founded in 2015, the company is immersed in the shift towards a new style of dentistry, 100% digitalised and personalised, with added value for dentists and patients. Since the start, more than 60 dental prosthesis labs have been integrated across Spain, France, Portugal, Netherlands and Belgium. This has been reinforced through a team of more than 1,200 professionals, offering differentiated and exclusive protocols in dentistry, across products, services, training, and education.
-
Asesores de Clearwater
Adviser to Adelis Equity on the sale of Nordentic to Corus
Ver más
Asesores de Clearwater
-
Jonathan Enqvist
Jonathan Enqvist Associate Director -
Andreas Klavebäck
Andreas Klaveback Associate Director
